European Reimbursement/Germany
Germany · DiGA · Permanent
Axia - für axiale Spondyloarthritis (axSpA)
Applimeda GmbH
About this entry
Axia - für axiale Spondyloarthritis (axSpA) is a digital health app from Applimeda GmbH with a permanent DiGA listing in Germany's DiGA directory (BfArM id 02856). It is indicated for ankylosing spondylitis / axial spondyloarthritis, inflammatory spondylopathies. First listed on 2026-02-04. The public prescription price is EUR 599 for a 90-day unit. German statutory health insurers reimburse prescribed use under the Digital Healthcare Act rules. This page is not legal or reimbursement advice; confirm the current entry on the official BfArM listing.
- App
- Axia - für axiale Spondyloarthritis (axSpA)
- Maker
- Applimeda GmbH
- Country
- Germany
- Program
- DiGA
- Status
- Permanent
- Indication detail
- M45 Spondylitis ankylosans; M46.8 Sonstige näher bezeichnete entzündliche Spondylopathien; M46.9 Entzündliche Spondylopathie, nicht näher bezeichnet; M00 Eitrige Arthritis; M01 Direkte Gelenkinfektionen bei anderenorts klassifizierten infektiösen und parasitären Krankheiten; +5 more
- Indication codes
- M45, M46.8, M46.9, M00, M01, C41.2, C79.5, M46.2, M46.3, M46.5
- Listing date
- 2026-02-04
- Permanent since
- 2026-02-04
- Public price
- EUR 599.00 per 90-day unit
- BfArM DiGA id
- 02856
Not legal or reimbursement advice. Confirm the current entry with the official source.